Management confirms FY2025 guidance, expects outperformance of Vision 2025 goals
Focus on profitability pays off: 9M/2025 Adj. EBITDA increases by +1.7%pts. vs. 9M/2024
US integration concluded, business model transformation ongoing, profitability developing favorably
Scientific evaluation of Fielmann’s Eye Health Checkup in Germany
Fielmann customers in Hamburg can now opt for an ophthalmologist exam as part of the scientific study
ZEISS Vision Care announced today that it has entered into a definitive agreement to acquire a 10% stake in Ocumeda at a total company valuation of €100m from Fielmann Group
Ocumeda is one of the leading tele-ophthalmology platforms in Europe connecting about 300,000 active patients and 700 optical retail stores with ophthalmologists and the medical community
On September 1, 2025, the 1,200 employees will move into the new Head Office on Fuhlsbuettler Strasse in Hamburg
The new Head Office of the world's third-largest provider of vision care and audiology promotes collaboration and exchange
With this location, the international family business is making a clear commitment to the Hanseatic city.
HY1/2025 figures in line with prognosis, make overachievement of Vision 2025 goals very likely
Vision 2035 envisages business evolution into a global provider of vision care and audiology
2030 targets: customer satisfaction of around 90%, global sales of approximately €4bn and an adjusted EBITDA margin of approximately 25% at Group level
Strong investor demand, significantly oversubscribed
Tranches priced at the lower end of the marketing range
Group’s capital structure and capital cost significantly improved
